ENDONOVO THERAPEUTICS, INC. Interest Expense
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Interest Expense of $941.57 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2022-04-14
- ENDONOVO THERAPEUTICS, INC. interest expense for fiscal 2021 was $941.57K, a 54.80% decline from fiscal 2020.
- ENDONOVO THERAPEUTICS, INC. interest expense for fiscal 2020 was $2.08M.
| Period end | Interest Expense 12 month |
|---|---|
| 2021-12-31 | $941.57K 10-K · filed 2022-04-14 |
| 2020-12-31 | $2.08M 10-K · filed 2022-04-14 |